CIK 0001041024
- Non-accelerated filer
- Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383317208
- Phone
- +1 800-449-3353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-07-07 | Gupta Ajay Chief Scientific Officer | Gift | −10,000 | 321,667 | ||
| 2015-06-12 | Gupta Ajay Chief Scientific Officer | Gift | −15,000 | 331,667 | ||
| 2015-05-01 | Pratt Raymond Dennis VP of Drug Development | Shares withheld for taxes | −34,650 | $9.64 | $334K | 155,700 |
| 2015-05-01 | KLEMA THOMAS E Vice President, CFO | Shares withheld for taxes | −27,440 | $9.64 | $265K | 494,740 |
| 2015-05-01 | Gupta Ajay Chief Scientific Officer | Shares withheld for taxes | −15,048 | $9.64 | $145K | 346,667 |
| 2015-05-01 | CHIOINI ROBERT L Chairman, President and CEO | Shares withheld for taxes | −73,200 | $9.64 | $706K | 1,783,933 |
| 2015-03-02 | Pratt Raymond Dennis VP of Drug Development | Shares withheld for taxes | −34,650 | $10.47 | $363K | 190,350 |
| 2015-03-02 | KLEMA THOMAS E Vice President, CFO | Shares withheld for taxes | −27,440 | $10.47 | $287K | 522,180 |
| 2015-03-02 | Gupta Ajay Chief Scientific Officer | Shares withheld for taxes | −31,500 | $10.47 | $330K | 361,715 |
| 2015-03-02 | CHIOINI ROBERT L Chairman, President and CEO | Shares withheld for taxes | −46,200 | $10.47 | $484K | 1,857,133 |
| 2014-12-22 | CHIOINI ROBERT L Chairman, President and CEO | Exercise or conversion | +335,000 | $2.79 | $935K | 2,163,333 |
| 2014-12-22 | CHIOINI ROBERT L Chairman, President and CEO | Shares withheld for taxes | −260,000 | $8.56 | $2.2M | 1,903,333 |
| 2014-12-22 | CHIOINI ROBERT L Chairman, President and CEO | Exercise or conversion · Stock Option (right to buy) | −335,000 | 0 | ||
| 2014-12-18 | BOYD RONALD D Director | Exercise or conversion | +12,500 | $2.79 | $35K | 17,500 |
| 2014-12-18 | BOYD RONALD D Director | Exercise or conversion | +12,500 | $2.79 | $35K | 12,500 |
| 2014-12-18 | BOYD RONALD D Director | Exercise or conversion · Stock Option (right to buy) | −12,500 | 0 | ||
| 2014-12-17 | KLEMA THOMAS E Vice President, CFO | Exercise or conversion | +57,500 | $2.79 | $160K | 607,120 |
| 2014-12-17 | KLEMA THOMAS E Vice President, CFO | Shares withheld for taxes | −57,500 | $8.32 | $478K | 549,620 |
| 2014-12-17 | KLEMA THOMAS E Vice President, CFO | Exercise or conversion · Stock Option (right to buy) | −57,500 | 0 | ||
| 2014-10-01 | Pratt Raymond Dennis VP of Drug Development | Grant or award | +75,000 | 225,000 |
Page 21 of 30 · 588 trades